Citation noticeOur citation system is being overhauled
References and citation markers may currently be incomplete, mismatched, or incorrect. This system is being rebuilt and reviewed before the full site launch.
5-Hydroxytryptophan
5-Hydroxytryptophan (5-HTP) is a naturally occurring amino acid and metabolic intermediate in the biosynthesis of serotonin and melatonin. It is sold as a dietary supplement for mood, sleep, and appetite-related purposes and is used medically in some countries for depression. Although several controlled trials report antidepressant effects, the available evidence lacks sufficient high-quality research. Combining 5-HTP with serotonin-releasing substances is not recommended.
Dosage & Duration
Dosage
Doses are population estimates that vary widely between individuals.
5-Hydroxytryptophan should not be taken concurrently with serotonergic substances. Following use of MDMA or similar serotonin-releasing agents, a minimum interval of 24 hours is advised before supplementation to reduce the risk of serotonin syndrome.
Duration
Subjective Effects
Pharmacology
Pharmacodynamics
5-HTP acts as a serotonin precursor, increasing serotonin production within central nervous system tissue. In rodents, high doses induce a head-twitch response that depends on conversion of 5-HTP to serotonin and is blocked by 5-HT2A receptor antagonists. This response is also abolished by inhibitors of indolethylamine N-methyltransferase, suggesting involvement of downstream N-methylated tryptamines.
Pharmacokinetics
5-HTP crosses the blood-brain barrier and is rapidly decarboxylated to serotonin by aromatic L-amino acid decarboxylase in nervous tissue and the liver. This conversion is vitamin B6 dependent. Excess 5-HTP, particularly when administered with vitamin B6, is thought to be metabolized and excreted.
Interactions
An unlisted combination is an unknown one, not a safe one. Check a dedicated combination chart before mixing.
Tolerance
Harm Potential
Toxicity
Prolonged use may carry a significant risk of heart valve disease. Rare adverse cardiovascular effects, typically reported at higher doses, include abnormal heartbeat, increased heart rate, and increased blood pressure.
Eosinophilia-myalgia syndrome, involving extreme muscle tenderness, myalgia, and blood abnormalities, has been associated with some 5-HTP supplements.
History & Culture
5-HTP has been used medically and as a dietary supplement under the international nonproprietary name oxitriptan, particularly for depression and other indications. It has been marketed under brand names including Cincofarm, Levothym, Levotonine, Oxyfan, Telesol, Tript-OH, and Triptum, and has also…
Legality
International
5-Hydroxytryptophan is not listed in the current INCB Yellow List under the 1961 Convention or Green List under the 1971 Convention, and it is not listed in either precursor table of the 1988 Convention.
By Country
References
Citations
- Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026. legislation.gov.au (n.d.). https://www.legislation.gov.au/F2026L00633/latest/text1
- Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026. tga.gov.au (n.d.). https://www.tga.gov.au/resources/publication/publications/poisons-standard-susmp1
- Portaria SVS/MS n.º 344/1998, Anexo I (listas atualizadas pela Anvisa). anvisalegis.datalegis.net (n.d.). https://anvisalegis.datalegis.net/action/ActionDatalegis.php?acao=abrirTextoAto&tipo=POR&numeroAto=00000344&seqAto=000&valorAno=1998&orgao=SVS/MS&codTipo=&desItem=&desItemFim=&cod_menu=1696&cod_modulo=134&pesquisa=true1
- Portaria SVS/MS n.º 344/1998, Anexo I (listas atualizadas pela Anvisa). gov.br (n.d.). https://www.gov.br/anvisa/pt-br/assuntos/medicamentos/controlados/lista-substancias1
- Natural Health Products Regulations (SOR/2003-196). laws-lois.justice.gc.ca (n.d.). https://laws-lois.justice.gc.ca/eng/regulations/SOR-2003-196/FullText.html1
- Natural Health Products Regulations (SOR/2003-196). health-products.canada.ca (n.d.). https://health-products.canada.ca/lnhpd-bdpsnh/info?licence=801029031
- INVIMA Resolution No. 2024027074 of 13 June 2024. webservice.invima.gov.co (n.d.). https://webservice.invima.gov.co/registros/pdf/16599091_2024027074.pdf1
- Vyhláška č. 58/2018 Sb., o doplňcích stravy a složení potravin. e-sbirka.gov.cz (n.d.). https://e-sbirka.gov.cz/sb/2018/581
- Vyhláška č. 58/2018 Sb., o doplňcích stravy a složení potravin. potravinynapranyri.cz (n.d.). https://www.potravinynapranyri.cz/EDetail.aspx?archive=actual&design=default&id=120&lang=cs&listtype=map1
- Bekendtgørelse om euforiserende stoffer nr. 405 af 26. marts 2026. retsinformation.dk (n.d.). https://www.retsinformation.dk/eli/lta/2026/4051
Article Status
Step 1 · Automated synthesisAn autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.
- Step 2 · First-pass reviewPending
Not yet reviewed — this article is pending editorial review by Lyrea.
- Step 3 · Citation reviewPending
No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.
Recent changes7 human edits · latest
Times are UTCNewest first
24 January 2026
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Suggest an edit
Spotted a mistake, an outdated claim, or something missing from the 5-Hydroxytryptophan article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.
Wish to give generalised feedback? You can do so here.